ibuprofen has been researched along with metoclopramide in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 11 (50.00) | 29.6817 |
| 2010's | 9 (40.91) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| DeHart, DA; Delaney, J; Ellis, GL; Owens, A | 1 |
| Acharya, MR; Conley, BA; Doroshow, JH; Figg, WD; Sausville, EA; Sparreboom, A; Venitz, J | 1 |
| Boey, FY; Tang, YD; Venkatraman, SS; Wang, LW | 1 |
| Gattani, S; Shiyani, B; Surana, S | 1 |
| Lee, WL; Loei, C; Loo, SC; Widjaja, E | 1 |
| Dragoman, MV; Dung, DL; Grossman, D; Habib, N; Huong, NM; Kapp, N; Tamang, A | 1 |
| Bhai, SF; Gregorie, WD; Harris, NS; Irons, HR; Salas, RN | 1 |
1 review(s) available for ibuprofen and metoclopramide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for ibuprofen and metoclopramide
| Article | Year |
|---|---|
The efficacy of metoclopramide in the treatment of migraine headache.
Topics: Adolescent; Adult; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Humans; Ibuprofen; Metoclopramide; Migraine Disorders; Treatment Outcome | 1993 |
Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days' gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Clinical Protocols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ibuprofen; Metoclopramide; Mifepristone; Misoprostol; Pain; Pain Management; Postoperative Nausea and Vomiting; Pregnancy; Research Design; Tramadol; Young Adult | 2016 |
Prospective Double-Blinded Randomized Field-Based Clinical Trial of Metoclopramide and Ibuprofen for the Treatment of High Altitude Headache and Acute Mountain Sickness.
Topics: Adult; Altitude Sickness; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Double-Blind Method; Female; Headache; Humans; Ibuprofen; Male; Metoclopramide; Middle Aged; Mountaineering; Nepal; Prospective Studies; Treatment Outcome; Young Adult | 2020 |
18 other study(ies) available for ibuprofen and metoclopramide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[More than six billions Euro costs due to illness days. Migraine therapy counts].
Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Aspirin; Cost of Illness; Costs and Cost Analysis; Domperidone; Dopamine Antagonists; Drug Therapy, Combination; Germany; Humans; Ibuprofen; Metoclopramide; Migraine Disorders; Serotonin Receptor Agonists; Sick Leave | 2003 |
Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor.
Topics: Animals; Area Under Curve; Benzamides; Binding, Competitive; Blood Proteins; Dogs; Glycoproteins; Half-Life; Histone Deacetylase Inhibitors; Humans; Ibuprofen; Metoclopramide; Mice; Neoplasms; Orosomucoid; Protein Binding; Pyridines; Rabbits; Rats; Serum Albumin; Species Specificity; Swine; Time Factors | 2006 |
Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form.
Topics: Alginates; Delayed-Action Preparations; Gastric Juice; Gels; Glucuronic Acid; Hexuronic Acids; Ibuprofen; Metoclopramide; Microscopy, Electron, Scanning; Niacinamide; Particle Size; Plant Oils; Polymethacrylic Acids; Polyvinyl Alcohol; Sunflower Oil; Water | 2007 |
Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Combinations; Drug Evaluation, Preclinical; Ibuprofen; Metoclopramide; Tablets | 2008 |
Altering the drug release profiles of double-layered ternary-phase microparticles.
Topics: Chromatography, Gel; Drug Carriers; Drug Compounding; Hydrophobic and Hydrophilic Interactions; Ibuprofen; Lactic Acid; Metoclopramide; Microscopy, Electron, Scanning; Molecular Weight; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Spectrum Analysis, Raman; Surface Properties | 2011 |